Evidence map›Paper›PMID 28881786›Full record

ArticleOncotarget2017

TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling.

Yun Peng, Jun Cao, Xiao-Yi Yao, Jian-Xin Wang, Mei-Zuo Zhong, Ping-Ping Gan, Jian-Huang Li

RetractedOpen access · diamondAbstract readRetracted Publication
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Up-regulation ofArchives of medical science : AMS · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TUSC3: functional duality of a cancer gene.Cellular and molecular life sciences : CMLS · 2018
    Review
  16. Article
  17. Article
  18. MicroRNA regulation of liver cancer stem cells.American journal of cancer research · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yun PengInternational Medical Center, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
Jun CaoDepartment of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410008, P.R. China.
Xiao-Yi YaoDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
Jian-Xin WangSchool of Information Science and Engineering, Central South University, Changsha 410008, P.R. China.
Mei-Zuo ZhongDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
Ping-Ping GanDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
Jian-Huang LiDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the effects of tumor suppressor candidate 3 (

Indexed as

A549 cellsautophagynon-small cell lung cancertumor suppressor candidate 3Wnt/β-catenin signaling pathway

Identifiers

PMID28881786
PMCPMC5581085
OpenAlexW2612241871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.